Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125394663 | 12539466 | 3 | F | 20130204 | 20160823 | 20160708 | 20160825 | EXP | JP-AMGEN-JPNSP2016088202 | AMGEN | TSUDA M, AKAZAWA S, DAIZUMOTO K ET AL.. EXPERIENCES OF USE OF DENOSUMAB FOR UROLOGIC CANCERS METASTASIS TO THE BONE. THE 104TH ANNUAL MEETING OF THE JAPANESE UROLOGICAL ASSOCIATION. 2016 | 85.00 | YR | E | M | Y | 62.00000 | KG | 20160825 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125394663 | 12539466 | 1 | PS | RANMARK | DENOSUMAB | 1 | Subcutaneous | 120 MG, UNK | 125320 | 120 | MG | SOLUTION FOR INJECTION | |||||||
| 125394663 | 12539466 | 2 | SS | ZOLEDRONIC ACID | ZOLEDRONIC ACID | 1 | Unknown | UNK | 0 | ||||||||||
| 125394663 | 12539466 | 3 | C | CALCIUM LACTATE | CALCIUM LACTATE | 1 | Oral | 1 G, TID | 1485 | G | 0 | 1 | G | TID | |||||
| 125394663 | 12539466 | 4 | C | ALFAROL | ALFACALCIDOL | 1 | Oral | 0.5 MUG, QD | 0 | .5 | UG | CAPSULE | QD | ||||||
| 125394663 | 12539466 | 5 | C | CELECOX | CELECOXIB | 1 | Oral | 100 MG, BID | 99000 | MG | 0 | 100 | MG | TABLET | BID | ||||
| 125394663 | 12539466 | 6 | C | KREMEZIN | ACTIVATED CHARCOAL | 1 | Oral | 2 G, TID | 2466 | G | 0 | 2 | G | TID | |||||
| 125394663 | 12539466 | 7 | C | KREMEZIN | ACTIVATED CHARCOAL | 1 | 2466 | G | 0 | ||||||||||
| 125394663 | 12539466 | 8 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, QD | 0 | 5 | MG | ORODISPERSIBLE TABLET | QD | ||||||
| 125394663 | 12539466 | 9 | C | PREDONINE | PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE | 1 | Oral | 5 MG, BID | 0 | 5 | MG | BID | |||||||
| 125394663 | 12539466 | 10 | C | NEXAVAR | SORAFENIB | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125394663 | 12539466 | 1 | Renal cancer |
| 125394663 | 12539466 | 2 | Product used for unknown indication |
| 125394663 | 12539466 | 3 | Hypocalcaemia |
| 125394663 | 12539466 | 4 | Hypocalcaemia |
| 125394663 | 12539466 | 5 | Bone pain |
| 125394663 | 12539466 | 6 | Chronic kidney disease |
| 125394663 | 12539466 | 7 | Chronic kidney disease |
| 125394663 | 12539466 | 8 | Hypertension |
| 125394663 | 12539466 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125394663 | 12539466 | OT |
| 125394663 | 12539466 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125394663 | 12539466 | Osteonecrosis of jaw | |
| 125394663 | 12539466 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125394663 | 12539466 | 1 | 20120803 | 20130823 | 0 | |
| 125394663 | 12539466 | 2 | 20120604 | 0 | ||
| 125394663 | 12539466 | 3 | 20120116 | 20130524 | 0 | |
| 125394663 | 12539466 | 4 | 20120803 | 0 | ||
| 125394663 | 12539466 | 5 | 20111128 | 20130405 | 0 | |
| 125394663 | 12539466 | 6 | 20120604 | 20130719 | 0 | |
| 125394663 | 12539466 | 8 | 2006 | 0 | ||
| 125394663 | 12539466 | 10 | 20120604 | 0 |